Ad
related to: merck
Search results
Merck (MRK) to Buy Private Ophthalmology Company EyeBio
Zacks via Yahoo Finance· 5 hours agoMerck's (MRK) acquisition of EyeBio is set to add the latter's lead pipeline candidate, Restoret, a...
Merck's Multi-Billion Cancer Drug Keytruda Aces Late-Stage Breast Cancer Study (UPDATED)
Benzinga via Yahoo Finance· 2 days agoEditor’s Note: The title of the story is updated to correct the reference to ‘Breast’ cancer instead...
Merck to Acquire EyeBio
Morningstar· 1 day agoMerck (NYSE: MRK), known as MSD outside of the United States and Canada, and Eyebiotech Limited (EyeBio), a privately held ophthalmology-focused biotechnology company, today ...
Germany's Merck, Korean science institute set up R&D partnership
dpa international via Yahoo News· 12 hours agoGerman science and technology major Merck and the Korea Advanced Institute of Science and Technology...
Merck to buy eye-focused drug developer EyeBio for as much as $3 billion
Reuters via AOL· 1 day ago(Reuters) -Merck on Wednesday agreed to buy privately held biotech EyeBio for as much as $3 billion,...
Merck KGaA (MKGAF) Upgraded to Buy: Here's What You Should Know
Zacks via Yahoo Finance· 1 day agoMerck KGaA (MKGAF) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2...
Healthy Returns: Pfizer, Merck, J&J and more to release cancer drug data at industry conference
CNBC· 2 hours agoThe company last week released a free new tool set called the AI Trust and Assurance Suite, which...
Surmodics Stock Rockets, But Merck Stock Little Moved, On Takeover Deals
Investor's Business Daily· 1 day agoDow Jones stalwart Merck and Surmodics announced big takeover deals Wednesday, but Merck stock...
Summit Therapeutics cancer therapy succeeds in late-stage China study
Reuters via AOL· 1 hour agoThe company said its therapy showed statistically significant improvement compared to Merck's Keytruda in a head-to-head setting. The study sponsored by Akeso showed the therapy ...
Merck to buy EyeBio in a deal that could valued at up to $3 billion
Market Watch· 1 day agoannounced Wednesday an agreement to buy privately held Eyebiotech Ltd., an ophthalmology-focused...
